Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection.

Loey Lung-Yi MakDanny Ka-Ho WongWai-Kay SetoQin NingKa-Shing CheungJames FungChing-Lung LaiMan-Fung Yuen

Published in: Hepatology international (2019)

Serum M2BPGi can risk-stratify CHB patients whose liver stiffness fell into the 'grey area'. Significant fibrosis regression occurring in one-quarter patients was reflected by a reduction in M2BPGi levels at 10-year interval.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
binding protein
peritoneal dialysis
patient reported outcomes
liver fibrosis